Chair, Molecular Medicine and Therapeutics
Pelotonia Research Center
2255 Kenny Rd.
Columbus, OH 43210
Matthew.Ringel@osumc.edu
Dr. Ringel is Professor and Chair of the Department of Molecular Medicine and Therapeutics at The Ohio State University where he holds the Ralph W. Kurtz endowed chair. He is also the Deputy Director for Basic Research of the OSU Comprehensive Cancer Center and Co-director of the Center of Cancer Engineering. Dr. Ringel’s NIH-funded laboratory for more than two decades has defined signaling pathways that regulate thyroid cancer progression and therapeutic resistance and has identified predisposing genes for thyroid cancer. He maintains an active clinical practice focused on thyroid cancer. He has been an elected board member of the American Thyroid Association and International Thyroid Oncology Group, co-chaired annual meetings of the ATA and ITOG and chaired the Endocrine Society Annual Meeting Committee. He is an elected member of the American Society of Clinical Investigation (ASCI) and also the American Association of Physicians (AAP) and has been awarded the Van Meter and Sidney Ingbar Awards from the American Thyroid Association (ATA) as well as the NCI Director’s service award from NIH. He currently is co-Chair of the ATA Thyroid Cancer Guidelines task force and is the Editor-in-Chief of Endocrine-Related Cancer.